Searched for
FDA BREAKTHROUGH STATUS
'Safeguards' slowing down access to breakthrough drugs in IndiaNew drugs are not reaching low and middle income countries. A study shows many medicines take years to become accessible globally. India's ...
Is Novo Nordisk facing its “Nokia moment”? Stock tumbles to $50 from a year-high of $139 amid disruptive rivals and shifting market forcesNovo Nordisk’s stock has tumbled from record highs after slashing its 2025 outlook, as fierce competition, leadership changes, and legal ch...
Gems & jewellery, textiles to carpets: How Trump’s tariffs are wrecking Indian MSMEsMajor labour-intensive sectors of the Indian economy, such as gems and jewellery, textiles, carpets and handloom are feeling the pinch of u...
Elon Musk’s Neuralink to implant Blindsight prosthesis in a human by 2025 endAccording to Musk, Blindsight is designed to allow those who have lost both eyes and their optic nerve to see and even enable individuals w...
Biden's pandemic fight: Inside the setbacks of the first yearVaccines had been the core of President Joe Biden's pandemic strategy from the moment he took office. But as Walensky was briefed about a c...
What does it mean to be 'fully vaccinated' against COVID-19?A few months ago, confirming full vaccination status was as simple as showing a card or QR code with proof that the required number of shot...
Datar gets USFDA breakthrough status for blood test to detect early-stage breast cancerThe blood test uses a proprietary technology developed by the company to detect circulating tumor cells and clusters specific to breast can...
UK begins major trial for new inhaler-based COVID-19 treatmentSynairgen's SG018 trial is a randomised placebo-controlled study being conducted in approximately 20 countries enrolling a total of 610 COV...
Bengalurean’s anti-cancer kit a breakthrough: USThe US Food and Drug Administration (FDA)’s Centre for Devices and Radiological Health has designated a medical invention by a Bengaluru-ba...
- Merck merges pharma, consumer health units; aims to ramp up businesses
Going against the grain: With the unique hybrid model for India, co aims at building scale & ramping up businesses.
Breakthrough cancer drugs all set for India launchThe accelerated regulatory clearances cut the time lines for introductions of the two big brands which may be expected to be introduced by ...
Wockhardt to enhance R&D capabilities in drug innovation: MDPharma firm Wockhardt will continue to strengthen its R&D capabilities to develop innovative and technologically advanced medicines, a top ...